The 2024 global microbiology report details the latest developments and trends shaping the field. This analysis covers innovations in molecular diagnostics, bioprocessing technologies, and microbial applications across various sectors. It highlights the importance of microbiology in healthcare, agriculture, and biotechnology and provides insights into how new technologies and methodologies drive efficiency and sustainability.
This microbiology report serves as a reference for stakeholders within the industry, investors, policymakers, and economic analysts, providing a snapshot of the industry’s health to map its trajectory for innovation and growth in the coming years.
StartUs Insights Global Microbiology Report 2024
- Executive Summary
- Introduction to the Global Microbiology Report 2024
- What data is used in this Global Microbiology Report?
- Snapshot of the Global Microbiology Industry
- Funding Landscape in the Microbiology Industry
- Who is Investing in Microbiology Solutions?
- Emerging Trends in the Microbiology Industry
- 5 Innovative Microbiology Startups
Executive Summary: Microbiology Report 2024
This report is created using data obtained from the Big Data and AI-powered StartUs Insights Discovery Platform, covering more than 4.7 million global companies, as well as 20K+ technologies and emerging trends. We also analyzed a sample of 730+ microbiology startups developing innovative solutions to present five examples from emerging microbiology industry trends.
- Industry Growth Overview: The microbiology industry features over 5480 companies. However, it has experienced a slight decline in annual growth of 1.22%.
- Manpower & Employment Growth: Global manpower stands at over 464400+ employees. The industry added more than 25800 new employees in the last year alone.
- Patents & Grants: It filed over 170390 patents and received more than 1020 grants received.
- Global Footprint: The industry’s primary hubs span across countries such as the USA, India, the UK, Germany, and Italy. Major city hubs include Hyderabad, London, New Delhi, Chennai, and Bangalore.
- Investment Landscape: The microbiology sector closed over 950 funding rounds with an average investment value of USD 15 million per round. The industry attracted more than 350 investors, investing in over 320 companies.
- Top Investors: The combined value invested by top investors exceeds USD 589 million. A few of these top investors include Sonic Healthcare, Battery Ventures, and FirstMark Capital.
- Startup Ecosystem: The top five innovative startups include Ogi Bio (microbial culturing), Stratix Labs (microbiology workflow products), Cultiply (intelligent fermentation), inbiome (molecular culture technology), and Fungit (plants probiotics).
- Recommendations for Stakeholders: Investors should prioritize funding startups focusing on microbial diagnostics and bioprocessing technologies. Developing solutions that address current challenges in microbiome analysis, fermentation processes, and sustainable agricultural practices using microbial technology, will benefit companies and entrepreneurs. Governments must increase funding for microbiology research, create incentives for microbial technology adoption, and support public-private partnerships.
Explore the Data-driven Microbiology Industry Report for 2024
The Microbiology Report 2024 uses data from the Discovery Platform and encapsulates the key metrics that underline the sector’s dynamic growth and innovation. The database features 730 startups and over 5480 companies. Despite a slight decline in industry growth of 1.22% per annum, the sector remains strong, with 170390+ patents and 1020+ grants awarded.
Global manpower stands at 464400+ employees to reflect the scale of the industry. Employee growth stays strong with 25800+ new employees added in the last year alone. The industry’s primary hubs span top countries such as the USA, India, the UK, Germany, and Italy. Major city hubs include Hyderabad, London, New Delhi, Chennai, and Bangalore indicating the global presence and concentration of industry activities in these regions.
What data is used to create this microbiology report?
Based on the data provided by our Discovery Platform, we observe that the microbiology industry ranks among the top 5% in the following categories relative to all 20K topics in our database. These categories provide a comprehensive overview of the industry’s key metrics and inform the short-term future direction of the industry.
- News Coverage & Publications: More than 4110 news articles were published on microbiology last year.
- Funding Rounds: The microbiology sector closed over 950 funding rounds.
- Manpower: The industry employs more than 464400 workers. Last year, it added more than 25800 new employees.
- Patents: Over 170390 technologies received patents in the microbiology industry.
- Grants: The industry was awarded 1020+ grants.
- Yearly Global Search Growth: The yearly global search growth for the microbiology industry stands at 5.29%.
- and more. Get in touch to explore all data points used to create this microbiology report.
A Snapshot of the Global Microbiology Industry
The microbiology industry has a workforce with over 464400 employees working for the sector. This segment of the industry saw growth by adding more than 25800 new employees last year. This demonstrates its expanding influence and capacity.
Explore the Funding Landscape of the Microbiology Industry
The industry is supported by several companies, with 5480+ firms contributing to its development. Investment in the microbiology sector is showcased with an average investment value of USD 15 million per round. The industry attracted over 350 investors who closed over 950 funding rounds. Further, more than 320 companies in the microbiology sector secured investments and highlighted the industry’s attractiveness to investors and its growth potential.
Who is Investing in Microbiology?
The combined value contributed by top investors in the microbiology industry exceeds USD 589 million. This financial backing underscores the industry’s potential and appeal to investors. Some of the top investors include:
- Battery Ventures backed 4 companies with a total of USD 65 million.
- Sonic Healthcare supported 3 companies, with an investment value of USD 385 million.
- FirstMark Capital contributed USD 37 million to 2 companies.
- Gold Hill provided financial backing of USD 65 million to 2 companies.
- Westbury Partners invested USD 37 million in 2 companies.
- and more. Contact us to explore all investment data in the microbiology industry.
Access Top Microbiology Innovations & Trends with the Discovery Platform
Synthetic Biology grows with 1039 companies identified. This sector employs 31400 individuals, with an addition of 5400 new employees in the last year. The annual trend growth rate for synthetic biology stands at 10.34%. This growth highlights the advancement in genetic engineering, biotechnology, and the development of biological systems.
The Molecular Genetics sector comprises 424 companies and employs 27900 individuals. The industry saw an increase of 1800 new employees in the past year. The annual trend growth rate for molecular genetics is 0.36%. It indicates steady but slow growth. Despite this rate, the field remains important for understanding genetic variations and their implications in health and disease.
Genome Editing advances with 265 companies identified. This sector employs 14100 individuals, with 1400 new employees added in the last year. The annual trend growth rate for genome editing is at 38.2%. This reflects the interest and developments in this area. The growth rate underscores the potential for innovations and the impact of genome editing on various sectors, including medicine, agriculture, and biotechnology.
5 Top Examples from 730+ Innovative Microbiology Startups
The five innovative startups showcased below are picked based on data including the trend they operate within and their relevance, founding year, funding status, and more. Reach out to find promising startups, emerging trends, or industry data specific to your company’s needs and objectives.
Ogi Bio provides Microbial Culturing
UK-based startup Ogi Bio advances microbial culturing by offering a modular, retrofittable device that automates routine tasks and removes repetitive tasks. Further, the modular culturing system, affordable and adaptable, mimics manual flask-culturing. It provides real-time analytics on culture performance and directly counts cells to identify strains. The device distinguishes cells from waste and measures growth and metabolism. Thus, it accelerates product and process development and increases team productivity.
Stratix Labs offers Microbiology Workflow Products
US-based startup Stratix Labs develops microbiology workflow products, Enverify, Instant Inoculator, ReadyNow, and UV-Confirm. Enverify provides microbial-coated test surfaces to evaluate surface sampling performance and enhance regulatory compliance and monitoring consistency. Instant Inoculator introduces reference microorganisms by simplifying workflows and eliminating preparation work in quality control testing. ReadyNow offers preserved, ready-to-use test carriers and enables remote and standardized disinfection testing. UV-Confirm features a self-contained device to monitor UV disinfection efficacy without microbial exposure. These products streamline processes, improve standardization, and accelerate testing timelines across industries.
Cultiply develops Intelligent Fermentation
Spanish startup Cultiply develops bioproducts through its Intelligent Fermentation method and produces compounds like proteins, enzymes, biofertilizers, and other biological derivatives. The startup uses advanced microbiology techniques for isolation, screening, and strain improvement to enhance the efficiency of microorganisms. Its molecular biology methods enable the design and construction of strains for the overproduction of high-value compounds. Moreover, custom-designed bioreactors ensure efficient and personalized production for each project.
inbiome builds Molecular Culture Technology
Netherlands-based startup inbiome provides molecular diagnostics with its Molecular Culture technology to enable faster bacterial diagnostics and microbiome analysis. This technology accelerates human healthcare by providing insights into bacteria in the body and reducing false negatives. Molecular Culture detects unknown, uncultivable, or antibiotic-treated bacteria without pre-selection. It uses a length-dependent amplicon separation method to profile bacterial species for analyzing species simultaneously and enabling unbiased microbiota profiling. This technology reduces healthcare costs while improving patient outcomes and promoting preventive healthcare. Moreover, it optimizes the technology for skin, respiratory, and oral microbiomes.
Fungit makes Plants Probiotics
Israeli startup Fungit develops microorganism-based biocontrol agents for shelf life extension and crop protection in agriculture. These agents protect crops against climate stress and prevent fungal diseases. They employ advanced biocontrol strategies for fungal species screening and isolation. Unique biobanks from stress-adapted plants support the startup’s product development. Thus, Fungit provides sustainable alternatives to chemical fertilizers and pesticides.
Gain Comprehensive Insights into Microbiology Trends, Startups, or Technologies
The 2024 microbiology industry report showcases the advancements in diagnostic technologies, bioprocessing, and microbial applications. As the industry continues to evolve, the integration of new techniques and interdisciplinary approaches will improve productivity. The ongoing collaboration between academia and industry will be essential in unlocking the potential of microbiology. Contact us to explore all 730+ startups and scaleups, as well as all industry trends impacting microbiology companies.
